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Direct immunoassays and their performance - theoretical
modelling of the effects of antibody orientation and associated
kinetics

D. Mackey, E. Kelly,
School of Mathematical Sciences
Dublin Institute of Technology
Kevin Street, Dublin 8, Ireland

R. Nooney and R.O’Kennedy
Biomedical Diagnostics Institute
Dublin City University
Glasnevin, Dublin 9, Ireland

Abstract
The orientation and activity of antibodies immobilized on solid surfaces are of direct
relevance to many immunosensing applications. We therefore investigate a mathematical
model which estimates the fraction of antibodies which are available for reaction in a
randomly adsorbed sample. Numerical simulations are presented which highlight the
separate effects of antibody orientation, accessibility and loss of binding ability on the
amount of captured antigen. The assay response can then be expressed as a function of
total antibody density and used for optimizing the surface coverage strategy under various
conditions.

1

Introduction

Direct immunoassays are well established methods for detecting a variety of analytes. However, in many cases the formatting and the development of the assay are performed by carrying
out a series of experiments where the key components (including antibodies, antigens, blocking
agents etc.) are assessed to determine the ideal combinations that yield the best performance
characteristics. In some cases this is based purely on a set of iterative serial dilutions of
components in combination with fixed concentrations of one component, but the exact selection of optimised parameters is often relatively poorly defined. In an attempt to develop
a more systematic approach to this procedure, we are proposing a theoretical model which
investigates the effect of many design parameters on the kinetics of a direct immunoassay, as
well as their relative importance under various conditions.
Many immunoassay technologies rely on the immobilization of detection antibodies on
solid interfaces for binding analytical targets such as pathogenic organisms, hormones or protein biomarkers for cardiovascular disease or cancer diagnostics. The most frequently used
immobilization strategies are physical or chemical adsorption, both of which result in random
1

orientation on the substrate and considerably reduced antigen-binding activity. This phenomenon, generally attributed to shielding of antibody active sites and molecule denaturation
upon contact with the surface, has been widely researched and described in the experimental
literature. Some studies, [1, 2], report that extremely small (typically less that 10%) fractions
of antibodies are still capable of binding antigen after immobilization. In addition, the functionality of immobilized antibodies is of great importance to other biomedical applications
(such as artificial tissues and implants or targeted drug delivery systems) as well as immune
reactions in vivo [3].
The amount of captured antigen has been studied as a function of antibody surface coverage both theoretically and experimentally by several authors [1, 2, 4, 3]. However, since the
density of adsorbed antibodies is known to affect their orientation, accessibility and binding
ability, it is often not clear which of these properties has a greater impact on the assay signal,
and their separate assessment can be difficult to achieve in practice [5]. The mathematical
model we are proposing aims to address this issue.
Our modelling strategy is based on the theory known as Random Sequential Adsorption
(RSA), which has been successfully used over the past few decades for describing monolayer
particle deposition in many physical and biological settings, [6, 7]. In the most standard
description, uniform particles are randomly and irreversibly placed onto a solid surface with
no overlap allowed (although generalized theories exist which remove these restrictions). The
process is continued until no more particles can be deposited and the so-called jamming
limit is reached. The RSA process in one dimension is referred to as the interval filling,
or car parking, problem and the jamming coverage (also known as the Rényi constant) was
calculated in [8] as CR ≈ 0.74756... This theory can be used for calculating the distribution
of adsorbed particles, as well as the gaps between them, at any moment during the deposition
process.
In addition, we have recently presented a mathematical model for quantifying the orientation and activity of antibodies immobilized on a solid surface, based on the RSA framework
[9]. In this model, the antibodies were represented by randomly oriented circles whose diameters cover a 1-dimensional substrate and a simple procedure was developed for estimating
the percentage of antibodies which allow antigen access out of total antibody coverage. The
obvious disadvantages of a one-dimensional formulation are the difficulties in describing all
orientation configurations and comparing essential model parameters (such as concentrations,
kinetic rate constants, etc.) to their experimentally determined counterparts; however, a thorough understanding of this basic model is essential before generalizations to higher dimensions
and more realistic physical problems can be constructed. In spite of its restrictive setting,
this modelling strategy produced promising results and showed good qualitative agreement
with previous experimental studies, [9, 10]. In particular, it reproduced the signal drop at
high surface densities under similar conditions to those reported in the literature, [1, 2, 11],
which indicates the possibility of a well-defined optimal antibody coverage (with obvious
implications for design considerations).
The current paper generalizes our previous model (which assumed uniform kinetic activity)
to address the more realistic situation where the ability of antibodies to bind antigen, as
described by the equilibrium dissociation constant (Kd ), depends on their immobilization
configuration. Experimental evidence suggests that the interaction with the solid surface has
a detrimental effect on the antibody activity and so we expect upright antibodies (which have
less contact) to retain higher binding ability than the ones lying flat on the substrate. This
generalization allows us to study antibody orientation and affinity separately and, through
2

extensive numerical simulations, to assess their relative importance in a variety of cases.
While the proposed model has some limitations, we believe it can offer new approaches
and insights into optimization of assay design. For example, the RSA methods outlined
above allow us to further differentiate between orientation and accessibility by investigating
the spacing between active sites of adjacent antibodies. Although the effect of antibody
orientation on antigen capturing activity has been widely investigated in the literature [1, 2,
5, 17, 18], the antibody gap distribution throughout the adsorption process is not a frequently
used parameter in assay optimization studies.

2

Mathematical model

2.1

Derivation of active coverage

The standard, one-dimensional RSA formulation assumes that equal size intervals are placed
randomly and sequentially at a fixed rate onto an infinite line, provided they do not overlap
already deposited intervals. The length of these intervals is irrelevant to the analysis but,
for convenience, it is usually assumed to be equal to 1. The kinetic approach detailed in [12]
introduces a gap density function P (x, t), which measures the number of gaps (empty spaces
between adsorbed particles) of length x at time t and can be calculated as follows,
(
t2 F (t) e−(x−1)t ,
if x ≥ 1
Rt
,
(1)
P (x, t) =
−xτ
2 0 τ F (τ ) e
dτ, if x < 1

where



F (t) = exp −2

Z

t
0


1 − e−u
du ,
u

(see also [7, 9]). The total coverage function is given by
Z t
Z ∞
F (τ ) dτ,
xP (x, t) dx =
θ(t) = 1 −
0

0

a non-dimensional quantity which represents the fraction of the line (or substrate) covered by
intervals (particles) at time t and converges in the long term to the jamming limit, or Rényi’s
constant,
lim θ(t) = CR = 0.74756...
t→∞

Antibodies are large Y-shaped molecules, comprised of two fragment antigen binding (Fab)
regions and a fragment crystallizable region (Fc). In random (non-directed) immobilization,
antibody orientation is usually described (see, for example, [2, 13, 14]) by one of the following
positions: “end on” (the ideal position, with the active Fab region pointing towards the
solution), “head on” (or Fab down), “flat on” and “side on” (both of which correspond, in
our 1-dimensional model, to a side orientation, as shown in Fig. 1). As mentioned in the
Introduction, a simple procedure was introduced in [9] for estimating the “active coverage”,
that is the fraction of antibodies whose Fab sites were accessible to antigens in solution,
out of total antibody coverage. The assumption made in this model was that an end-on
(“Up”) antibody is unconditionally accessible, while a side-oriented antibody is accessible
provided there is a gap of length at least δ between its binding site and the adjacent adsorbed
particle (where the parameter δ is related to the size of the antigen of interest). The head-on
3
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Figure 1: Antibody structure and immobilization orientations. In our 1-dimensional description, an antibody can adsorb either “Up” (end-on), “Down” (head-on) or “Side” (flat-on or
side-on).

(“Down”) antibodies are considered inaccessible. The active coverage can then be written
as B(t) = Bu (t) + Bs (t), where Bu (t), Bs (t), are coverages by “up” (end-on) and accessible
side-on antibodies, respectively, and were calculated (using the gap density function) as, [9],
Bu (t) = Pup θ(t),


Z t
−δτ
−τ
Bs (t) = 2Pside tF (t) + 2 (e
− e )F (τ )dτ
0
 Rt
−δτ − e−2δτ ) F (τ ) dτ,
if 2δ < 1

2 0 (e
2
−(2δ−1)t
,
− Pside × tF (t) (1 − e
)

R t −δτ

−τ
+ 2 0 (e
− e )F (τ ) dτ, if 2δ ≥ 1

(2)

(3)

where Pup , Pside are the percentages of particles in the corresponding orientations. We normalize the active and total coverages by defining
B=

B
,
CR

θ=

θ
,
CR

so that
0 ≤ B(t) ≤ 1,

0 ≤ θ(t) ≤ 1,

for all t.
Note that this calculation simplifies the particle geometry by assuming that its width is
equal to its height. A more general approach to estimating active surface coverage was given
in [10], where the end-on and side-on configurations occupy intervals of different sizes and
the antibody aspect ratio is introduced in the analysis as yet another parameter which might
influence the assay behaviour.

2.2

Antibody-antigen reaction kinetics

If we consider the end-on and side-on antibodies as different species, with concentrations
denoted by Bu and Bs , and possibly different kinetic abilities, we can write the following
reactions:
ku

ku

A + Bs ⇄ Cs ,

A + Bu ⇄ Cu

′
ku

′
ku
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(4)

where A is the antigen concentration, Cu and Cs are concentrations of bound antigen, while
ku , ks and ku′ , ks′ are the association and dissociation rate constants, respectively. The reaction
rates are then given by the differential equations
dCu
= ku A(t) (Bu0 − Cu (t)) − ku′ Cu (t),
dt
dCs
= ks A(t) (Bs0 − Cs (t)) − ks′ Cs (t),
dt
where all concentrations are functions of time and Bs0 , Bu0 are the initial concentrations of
immobilized antibody. We also let
Kdu =

ku′
,
ku

Kds =

ks′
ks

be the equilibrium dissociation constants for the two antibody species, commonly used as a
measure of binding affinity. (Recall that high Kd values imply low affinity and vice-versa.)
dCs
u
The equilibrium condition is dC
dt = dt = 0, and we find that the steady-state values of
the reaction products Cu and Cs satisfy the coupled equations
Cu =

Cs Kds Bu0
,
Cs Kds + Kdu (Bs0 − Cs )

(5)

(Bs0 − Cs )(A0 − Cu − Cs ) − Kds Cs = 0

(6)

where A0 is initial antigen concentration and we used the conservation law A(t) + Cu (t) +
Cs (t) = A0 . In order to make use of the RSA results discussed in Section 2.1, we must relate
the initial active antibody concentrations to coverages as follows,
0
Bu,s
=

Bu,s CR
Bu,s
=
≡ κB u,s ,
D
D

where D is the diameter (or length, in our 1-dimensional model) of the antibody molecule,
while Bu,s are the initial active coverages, as calculated by (2)-(3). For the purpose of our
theoretical model it is simpler to express concentrations as number of molecules per unit
length (which is equivalent to the concept of molar concentration). The constant κ = CR /D
can then be interpreted as the concentration of antibodies corresponding to the jamming
coverage CR .
The use of scaled (or non-dimensional) variables greatly facilitates the analysis and numerical simulations of mathematical equations and also allows them to be viewed in a more general
context. For example, θ̄ = 1 refers to maximum (jamming) coverage, a concept common to
any adsorption model (even though the jamming values for generalized RSA frameworks are
different). Thus, the non-dimensional form of equations (5)-(6) become
Cs ψs Bu
,
Cs ψs + ψu (B s − Cs )
(B s − Cs )(α − Cu − Cs ) − ψs Cs = 0
Cu =

where
α=

A0
,
κ

Cu,s =

Cu,s
,
κ
5

ψu,s =

Kdu,s
κ

(7)
(8)

Table 1: Non-dimensional parameters used in the model
Symbol
CR
δ
θ
θ̄
Bu,s
B
B u,s
B
κ
α
ψu,s
Cu,s
C

Physical interpretation
maximum (jamming) coverage in the 1d RSA model
(CR = 0.74756..)
ratio of antigen diameter to antibody diameter
total coverage, 0 ≤ θ ≤ CR
normalized total coverage, 0 ≤ θ̄ ≤ 1
coverage by end-on/accessible side-on antibodies
active coverage (all accessible antibodies)
normalized coverage by end-on/accessible side-on antibodies
normalized active coverage (total)
maximum antibody concentration (jamming limit)
normalized antigen concentration
normalized affinity constants for end-on/side-on antibodies
normalized reaction product (signal) resulting from
end-on/side-on antibodies
total normalized reaction product (signal).

are the normalized antigen concentration, product concentrations and affinity constants, respectively. By substituting (7) into (8), we obtain a cubic equation which can be solved to
yield first Cs and then Cu . The total antigen bound to antibody is calculated as
C = Cu + Cs

(9)

and used in our simulations as a measure of the assay signal. The non-dimensional parameters
introduced above are summarized in Table 1.
For situations when there is no distinction between the affinities of end-on and side-on
antibodies (provided they are active), an equivalent but simpler approach would be to use a
single reaction
k

A + B ⇄ C,
k′

with associated differential equation
dC
= kA(t) (B 0 − C(t)) − k′ C(t),
dt
which, after using the conservation law A(t) + C(t) = A0 and the non-dimensionalization
procedure described above, yields the signal


q
1
2
(10)
C=
ψ + α + B − (ψ + α + B) − 4αB
2
(In these kinetically uniform cases we used the notation k = ku = ks , k′ = ku′ = ks′ , ψ = ψu =
ψs , etc.)

3

Numerical simulations

The signal (or bound antigen concentration) calculated from either (9) or (10) can now be
plotted against the total antibody coverage θ̄ in order to assess how the surface density
6

affects the assay behaviour. A similar analysis, where C is considered a function of antigen
concentration, α, and used to generate theoretical dose-response curves, will be the subject
of future work.

3.1

Discussion of model parameters

We now give a brief discussion of parameter values used for the numerical simulations.
Antibody orientation, Pup , Pside .
The percentages of antibodies adsorbed in the “up” and “side” configurations are known to
vary with surface coverage: experimental evidence suggests that antibodies are more likely to
lie flat at low surface coverage while crowding may favour an upward orientation, [1, 13, 15].
However, for simplicity, we assume here that Pup and Pside are constant throughout the deposition process. (Numerical simulations with nonconstant probabilities were presented in
[9] but the corresponding signal curves did not display any significantly different behaviour.)
Exact values for the antibody orientation parameters Pup and Pside are difficult to determine
from practical information but we can study various theoretical possibilities and their outcomes. These are summarized in Table 2 and can be described as follows: “Side 1” and “Side
2” refer to cases when the side-on particles are prevalent, thus 90% of antibodies are found
in this configuration at all adsorption stages. These two cases are further distinguished by
the percentage of antibodies adsorbing in the other configurations: 9% (and 5%, respectively)
have the end-on orientation, which implies that the remaining 1% (or 5%, respectively) are
head-on and thus unaccessible. Note also that the “Up 1” case describes the most desirable
Table 2: Various orientation possibilities used for the numerical simulations. The values Pup
and Pside indicate the percentages of antibodies in the end-on and side-on configurations,
respectively.
Side 1:
Pup = 0.09
Pside = 0.9
Side 2:
Pup = 0.05
Pside = 0.9

Mixed 1:
Pup = 0.45
Pside = 0.5
Mixed 2:
Pup = 0.25
Pside = 0.5

Up 1:
Pup = 0.81
Pside = 0.1
Up 2:
Pup = 0.45
Pside = 0.1

situation when the end-on orientation predominates, while the “Mixed 2” case assigns equal
adsorption probabilities to the four orientations possible in this one-dimensional model (up,
down, left and right, as illustrated in Fig 1). Other orientation probabilities can be easily
added to the study; however, we believe that the cases shown here represent a wide enough
sample of all typical immobilization configurations.
Antibody affinity, ψu , ψs .
As discussed in the Introduction, the binding activity of antibodies could be affected by immobilization, regardless of whether they are accessible to antigens or not. Since the extent of this
affinity deterioration is not precisely known, we investigate the following three possibilities:
Case 1 (High affinity): All immobilized antibodies, regardless of orientation, retain normal binding activity, similar to that displayed in solution.
Case 2 (Low affinity): All immobilized antibodies, regardless of orientation, have reduced
binding activity.
7

Case 3 (Mixed affinity): The side-on immobilized antibodies have reduced binding activity while the end-on antibodies retain their normal activity.
These possibilities are summarized in Table 3 below. It is difficult to calculate numerical
values for the normalized affinity constants ψu and ψs based on real equilibrium dissociation constants described in the experimental literature, as we are employing an abstract
1-dimensional model (as discussed in the Introduction). Instead, the values 0.1 and 0.001
proposed in Table 3 are arbitrary affinity values that accurately capture the qualitative shift
in the behaviour of signals. Values greater than 0.1 produce small signal curves due to
the increased dissociation rate constant which results in a reduction of successfully bound
antigen-antibody complexes. Furthermore, ψ values less than 0.001 display signals similar to
ψ = 0.001 curves due to the inherent saturation effect.
Table 3: Different cases of antibody binding activity, based on affinity constants
Case 1
Case 2
Case 3
(High affinity) (Low affinity) (Mixed affinity)
ψu = ψs = 0.001

ψu = ψs = 0.1

ψu = 0.001, ψs = 0.1

Antigen size, δ.
The size of the antigen relative to the detection antibody can vary greatly between assays
and it has been shown to significantly affect the complex formation, [15]. In our study, we
consider two possibilities: δ = 1 (corresponding to large antigens assumed, for simplicity, to
have the same diameter as the antibody) and δ = 0.1 (small antigens). Recall that, in the
RSA framework discussed in Section 2, the adsorbed particles (antibodies) have unit length.
Antigen concentration, α.
As the signal is studied as a function of immobilized antibody density, the antigen concentration is assumed constant. We use the values α = 0.5 (low) and α = 5 (high) for the
normalized antigen concentration, which correspond to antigen concentrations equal to half
and five times, respectively, the maximum immobilized antibody concentration. (See Table 1.)

3.2

Effect of antibody orientation and affinity on the assay signal

The first set of simulations compares the assay signals when the antibody orientation on the
surface varies according to the six possibilities presented in Table 2. This analysis is repeated
for all three affinity cases (high, low and mixed), two different antigen sizes (small and large)
as well as two different antigen concentrations (low and high). The results are presented
in Figures 2-4. Note that the signals (or normalized reaction products C) are given here as
functions of the total antibody coverage, θ̄, and not just the functional antibody fraction.
The maximum value on the horizontal axis, θ̄ = 1, represents the normalized jamming limit
(CR = 0.74756.., in the one-dimensional RSA formulation) which, for practical purposes, can
be interpreted as a fully packed monolayer.
It is seen that for large antigens, different orientations of immobilized antibodies yield
a wide range of signal shapes and amplitudes, while smaller antigens lead to less variety
in the assay behaviour. This can be explained by noting that smaller antigens have better
accessibility so immobilized side-on antibodies are thus more likely to be active, at both
low and high surface coverage. Of significant practical interest is the “hooked” response
8
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Figure 2: Comparison of different antibody orientations for Case 1 (high affinity, ψu = ψs =
0.001), for both small (δ = 0.1, right) and large (δ = 1, left) antigens, at high (α = 5, top
panels) and low (α = 0.5, bottom panels) concentrations.

(signal decline at high antibody concentrations), which possesses a well-defined maximum
value corresponding to optimal surface coverage. Our simulations suggest that hook curves
occur when the side orientation predominates and the effect is more pronounced for large
antigens. (For small antigens, the signal decline happens later, near maximal coverage, and is
less significant). Similar qualitative behaviour has been widely reported in the experimental
literature, [1, 2, 11, 17]. For example, the results in [2] show that antigen-binding rates reach a
maximum value when antibody coverage is low and a decrease in binding activity is observed
at higher antibody concentrations. A flat-on orientation of antibodies is determined using
neutron reflection (NR) measurements and the antigen used in this work is human chorionic
gonadotrophin (hCG), characterized as a large, elongated molecule. Such an experimental
configuration would correspond, in our simulations, to the parameter values associated with
the side orientation (black) curves in Figures 2(a), 3(a) or 4(a). By contrast, linearly increasing
curves (which is the desirable qualitative signal behaviour) are associated with excess antigen
and either small antigens or large antigens with favourable (Up) orientation.
The second set of simulations (shown in the Supplementary Information, Figures S1-S3)
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Figure 3: Comparison of different antibody orientations for Case 2 (low affinity, ψu = ψs =
0.1), for both small (δ = 0.1, right) and large (δ = 1, left) antigens, at high (α = 5, top
panels) and low (α = 0.5, bottom panels) concentrations.
compare the signal curves associated with different antibody binding abilities. From these
simulations (and similar ones with different α values) it appears that assigning different
binding abilities to antibodies has no effect on the signal shape or strength at high antigen
concentrations and only a small effect at low concentrations. This is not surprising as, in the
case of excess antigen, the amount that is bound will be limited by the available antibody and
hence the corresponding (solid) curves in Figures S1-S3 also represent the fraction of active
antibody coverage.
Another observable difference between the various kinetic abilities studied above is the
flattening of the signal curves near jamming, which occurs at low antigen concentrations when
at least some of the antibodies retain high activity (Figures 2 and 4, corresponding to Case
1 and Case 3), but not when the affinity is uniformly low (Figure 3, Case 2). The presence
of such signal saturation states can be explained by insufficient antigen under favourable
antibody operating conditions (good affinity and orientation).
Finally, comparing the two sets of simulations shown in Figures 2-4 and Figures S1-S3, our
model suggests that antibody orientation (and therefore accessibility of binding sites) has more
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Figure 4: Comparison of different antibody orientations for Case 3 (mixed affinity, ψu = 0.001,
ψs = 0.1), for both small (δ = 0.1, right) and large (δ = 1, left) antigens, at high (α = 5, top
panels) and low (α = 0.5, bottom panels) concentrations.

impact on the assay behaviour than its affinity (especially at high antigen concentrations).
A similar conclusion was reached in [18] where the binding between hCG and immobilized
anti-hCG was studied on various surface types and the antigen-antibody ratio was found to
be affected mainly by orientation rather than decrease in antibody bioreactivity.

4

Conclusions

We have presented a mathematical model which describes antibody adsorption and distribution on a solid surface using a one-dimensional RSA framework (where particle diameters
are equivalent to intervals filling a line) and estimates the fraction of functional antibodies as
a function of surface coverage, using parameters such as orientation probability and size of
antigen. The total amount of antigen bound (or assay signal) is then theoretically predicted
for various orientation configurations and degrees of affinity loss.
We note that this modelling strategy deals with features common to many different assays
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rather than focussing on a specific case study. For example, surface properties (charge,
hydrophobicity, etc.) and bulk concentration of antibodies are known to affect their adsorption
and orientation [13] and are reflected by the Pup , Pside parameters, while particular choices
of the antibody-antigen pair are described by δ, α, ψ, etc. Various published experimental
studies corresponding to specific choices of these parameters were cited throughout the paper
to complement our theoretical simulations.
Many studies [14, 5, 16] have shown that assays using well-oriented antibodies (achieved,
for example, with bioaffinity immobilization techniques) exhibit better binding efficiency and
sensitivity compared to randomly oriented ones. Although orientation of antibodies is known
to affect their affinity, in this modelling framework we have considered these properties independently and shown that orientation has a more pronounced effect on complex formation
than affinity. Thus, our model suggests that the poor performance displayed by randomly
immobilized particles results mainly from reduced accessibility and, to a lesser extent, from
impaired binding ability.
In order to facilitate the analytical and numerical study of this model, the geometric and
kinetic features of the assay were greatly simplified. For example, only three different antibody orientations were considered (up, down, side) and the “Up” antibodies were assumed
to be unconditionally accessible. Moreover, the immobilized particles were assumed rigid in
this framework, with no possibility of further movement, shape change or overlap. These
restrictions will be removed in future studies and there is huge potential for modelling other
adsorption and transport effects, as sensors often rely on microfluidic elements and particle immobilization on spherical surfaces. In spite of the simplifying assumptions mentioned
above, the model gives good qualitative agreement with experimental observations and we
can conclude that a theoretical approach to assay optimization, which quantifies the effect of
various design parameters on the signal curves, is feasible and adaptable to many physical
settings.
It is still common practice in immunoassay preparation to adsorb antibodies onto the
solid surface until saturation is reached as it is believed that a higher density would reduce
the possibility of structural unfolding and yield better performance (see comments in [2]).
However, practical studies have reported seemingly contradictory situations where densely
packed antibodies were either seen to improve antigen binding as a consequence of favourable
outward orientation [1], or else decrease it due to steric hindrance effects [17]. Our theoretical
model shows that the assay behaviour at high antibody densities depends on many system
parameters such as antibody orientation, relative size and concentration of antigen, etc. and
therefore a different design approach is needed in each of the cases arising from this analysis.
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